| scholarly article | Q13442814 |
| P50 | author | Jean-Charles Grivel | Q50223411 |
| Roberto F Speck | Q60061521 | ||
| P2093 | author name string | B Herndier | |
| M A Goldsmith | |||
| D A Eckstein | |||
| M L Penn | |||
| L Margolis | |||
| B Schramm | |||
| N W Abbey | |||
| P2860 | cites work | Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease | Q29616432 |
| Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection | Q29619099 | ||
| The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. | Q33782350 | ||
| Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis. | Q33784940 | ||
| CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue | Q34838416 | ||
| Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. | Q35874433 | ||
| Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop | Q35893615 | ||
| CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. | Q39033862 | ||
| Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. | Q39160304 | ||
| Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread | Q39529308 | ||
| CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. | Q39583317 | ||
| Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. | Q41096686 | ||
| Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals | Q41472104 | ||
| Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. | Q45763843 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 5347-5351 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue | |
| P478 | volume | 74 |
| Q46383565 | Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic |
| Q37059664 | CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure |
| Q33990498 | Caveolin-1 modulates HIV-1 envelope-induced bystander apoptosis through gp41. |
| Q35252587 | Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection |
| Q34342429 | Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence |
| Q35020604 | Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression |
| Q33854835 | Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status |
| Q33811663 | Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1 |
| Q24562082 | Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue |
| Q45068171 | Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses |
| Q39588193 | Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir |
| Q57081259 | Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors |
| Q37583423 | Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4. |
| Q36370102 | HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells |
| Q46126584 | HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues |
| Q64264398 | HIV-1 and SIV Infection Are Associated with Early Loss of Lung Interstitial CD4+ T Cells and Dissemination of Pulmonary Tuberculosis |
| Q36384710 | HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo |
| Q35897398 | HIV-1 vaginal transmission: cell-free or cell-associated virus? |
| Q37483781 | Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses |
| Q52639187 | Histoculture and Infection with HIV of Functional Human Lymphoid Tissue on Gelfoam®. |
| Q37102101 | Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment. |
| Q33848419 | Human immunodeficiency virus type 1 (HIV-1) non-B subtypes are similar to HIV-1 subtype B in that coreceptor specificity is a determinant of cytopathicity in human lymphoid tissue infected ex vivo |
| Q21559666 | Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequence |
| Q34977020 | In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells |
| Q35635009 | Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry |
| Q36399551 | Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. |
| Q37366730 | Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets |
| Q36242558 | Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa |
| Q35150119 | Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages |
| Q39682314 | Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo |
| Q34349213 | Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. |
| Q37348991 | R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. |
| Q30448634 | R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression |
| Q34301688 | R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors |
| Q37163016 | Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection. |
| Q42094434 | Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes |
| Q30441682 | The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1. |
| Q39300702 | The role of the alternative coreceptor GPR15 in SIV tropism for human cells |
| Q42709876 | Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1. |
| Q36189818 | Use of human tissue explants to study human infectious agents |
| Q46169742 | Viral entry as therapeutic target. Current situation of entry inhibitors |
Search more.